4Filed Sep 2, 8:00 PM ET
Omada (OMDA) CEO Sean Duffy Exercises Options and Sells Shares
$OMDA · Omada Health, Inc.Research Summary
AI-generated summary of this SEC filing
Omada (OMDA) CEO Sean Duffy Exercises Options and Sells Shares
What Happened
- Sean P. Duffy, Chief Executive Officer of Omada Health (OMDA), exercised stock options for a total of 21,572 shares on Sept 1, 2026, paying aggregate exercise prices of about $150,657 (three tranches: 12,944 @ $5.82 = $75,334; 4,314 @ $8.28 = $35,720; 4,314 @ $9.18 = $39,603).
- On the same date he sold 21,572 shares in open-market transactions for roughly $509,465 (multiple trades at weighted average prices: 7,344 @ $23.12 = $169,782; 5,600 @ $24.27 = $135,901; 4,933 @ $23.13 = $114,100; 3,695 @ $24.27 = $89,682).
- Separately, 9,885 shares were surrendered/ disposed to cover the exercise price or tax liability (reported at $22.84 each, totaling $225,773). Several zero-dollar derivative dispositions in the filing reflect conversion/settlement mechanics related to the exercises.
Key Details
- Transaction date: Sept 1, 2026.
- Option exercises: 21,572 shares; total cash paid ≈ $150,657.
- Open-market sales: 21,572 shares; sale proceeds ≈ $509,465 (weighted-average prices; see filing footnotes for trade ranges).
- Tax/exercise withholding: 9,885 shares surrendered, proceeds/value ≈ $225,773.
- Footnotes: sales were executed in multiple trades (weighted-average prices reported; full trade details available on request). Transactions were made pursuant to a 10b5-1 trading plan adopted Mar 13, 2026. Shares referenced include holdings in family trusts (reporting person disclaims beneficial ownership except to extent of pecuniary interest). All options exercised were 100% vested.
- Shares owned after the transactions: not specified in the excerpt provided.
Context
- This filing shows an option exercise followed by substantial sales and a share surrender to cover taxes/exercise costs — typical of a "sell-to-cover" or immediate post-exercise sale rather than an open-ended buy. Such transactions are common for executives monetizing vested options; they are not in themselves a clear signal of company outlook.
- The presence of a 10b5-1 trading plan indicates the sales were prearranged, which can reduce concerns about trading on nonpublic information.